Free Trial

RXO (RXO) Stock Forecast & Price Target

RXO logo
$23.69 -1.31 (-5.24%)
(As of 02:29 PM ET)

RXO - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
12
Buy
3

Based on 17 Wall Street analysts who have issued ratings for RXO in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 12 have given a hold rating, and 3 have given a buy rating for RXO.

Consensus Price Target

$26.47
11.72% Upside
According to the 17 analysts' twelve-month price targets for RXO, the average price target is $26.47. The highest price target for RXO is $33.00, while the lowest price target for RXO is $12.00. The average price target represents a forecasted upside of 11.72% from the current price of $23.69.
Get the Latest News and Ratings for RXO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for RXO and its competitors.

Sign Up

RXO Analyst Ratings Over Time

TypeCurrent Forecast
12/24/23 to 12/23/24
1 Month Ago
11/24/23 to 11/23/24
3 Months Ago
9/25/23 to 9/24/24
1 Year Ago
12/24/22 to 12/24/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
12 Hold rating(s)
12 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$26.47$26.47$26.00$20.08
Forecasted Upside11.72% Upside-6.68% Downside-4.06% Downside-15.93% Downside
Consensus Rating
Hold
Hold
Hold
Reduce

RXO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RXO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

RXO Stock vs. The Competition

TypeRXOTransportation CompaniesS&P 500
Consensus Rating Score
2.06
2.61
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside5.87% Upside43.89% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent RXO News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/18/2024The Goldman Sachs Group
2 of 5 stars
J. Alliger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral$29.00+6.42%
11/12/2024Susquehanna
2 of 5 stars
 Lower TargetNegative ➝ Negative$16.00 ➝ $12.00-57.60%
11/12/2024Citigroup
3 of 5 stars
A. Rosa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$33.00 ➝ $33.00+12.21%
11/11/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Poliniak-Cusi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$31.00+4.06%
10/15/2024Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
9/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$31.00 ➝ $31.00+19.37%
The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…
8/13/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$33.00 ➝ $31.00+13.51%
8/12/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$19.00 ➝ $26.00-7.70%
8/8/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$23.00 ➝ $28.00-4.27%
8/8/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$25.00 ➝ $26.00-12.84%
8/8/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$22.00 ➝ $31.00+6.90%
7/16/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$24.00 ➝ $30.00+0.10%
5/15/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
5/6/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$22.00+6.08%
2/8/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$25.00 ➝ $22.00+3.04%
1/10/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$20.00 ➝ $22.00-0.54%
1/10/2024Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$23.00+2.54%
7/12/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradePeer Perform ➝ Underperform$18.00-18.11%
2/27/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$22.00+8.43%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:48 PM ET.


RXO Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for RXO is $26.47, with a high forecast of $33.00 and a low forecast of $12.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RXO in the last year. There are currently 2 sell ratings, 12 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RXO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RXO, but not buy additional shares or sell existing shares.

According to analysts, RXO's stock has a predicted upside of 11.72% based on their 12-month stock forecasts.

Over the previous 90 days, RXO's stock had 1 downgrade by analysts.

RXO has been rated by research analysts at Benchmark, Citigroup, Susquehanna, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.

Analysts like RXO less than other "transportation" companies. The consensus rating for RXO is Hold while the average consensus rating for "transportation" companies is Moderate Buy. Learn more on how RXO compares to other companies.


This page (NYSE:RXO) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners